Two Sigma Securities’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Two Sigma Securities’s Portfolio VINC Stock Details VINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,053	Closed	-$5.85K	–	2250
2025 Q1	$5.85K	Buy	+11,053	New	+$18.2K	﹤0.01%	1290
2022 Q4	–	Sell	-1,339	Closed	-$37K	–	3388
2022 Q3	$37K	Buy	+1,339	New	+$38.5K	﹤0.01%	2224

Other funds holding VINC

BTC

Bank & Trust Company Litchfield, Illinois $158M AUM 35.48% 1-Year Est. Return

Two Sigma Securities's VINC Position: Q2 2025 in Review

Two Sigma Securities sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q2 2025, closing a stake of 11,053 shares — an estimated $5.85K sold.

Two Sigma Securities first reported a position in VINC in Q3 2022 and held it in 2 quarters. The position peaked at $37K in Q3 2022. 1 fund tracked by Wall St. Rank holds VINC as of Q2 2025.

Two Sigma Securities reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
Two Sigma Securities sold 11,053 Vincerx Pharma, Inc. Common Stock shares in Q2 2025, an estimated $5.85K.
Two Sigma Securities first reported a position in Vincerx Pharma, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
Two Sigma Securities's Vincerx Pharma, Inc. Common Stock position peaked at $37K in Q3 2022.
1 fund tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.